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Abstract
Background: Porcine epidemic diarrhea virus (PEDV) is the main causative agent of porcine epidemic diarrhea (PED).
Since December 2010, a large-scale outbreak of diarrhea has been observed in swine farms in China. Accumulated
evidence indicates that this large-scale outbreak of diarrhea were caused by highly virulent PEDV variants.
Methods: A PEDV strain, YC2014, was isolated from intestinal samples of suckling piglets with acute diarrhea in 2014.
The complete genomic sequence of YC2014 and the nucleotide sequence of S gene were aligned with sequences of
published isolates using MEGA 5.1 software. The immune protective efficiency of YC2014 were determined by testing
PEDV neutralizing antibodies in sera, the colostrum and the milk on 7th day after farrowing of the immunized sows.
The diarrhea symptoms of piglets after challenge were also observed.
Results: Phylogenetic analysis of the complete genomic sequence of YC2014 and the nucleotide sequence of S gene
demonstrated that the YC2014 PEDV strain was clustered with the PEDV epidemic strains, with >99 % nucleotide
identity to these PEDV strains. The S gene sequence of YC2014 shared only 93.9 % ~ 94.4 % identities with classical
CV777, DR13 and JS2008 strains, with 15 nucleotide insertion in three sites and three nucleotide deletion in one site.
The amino acid (AA) sequence of S gene of YC2014 shared only 92.8 % ~ 93.4 % identities with classical CV777, DR13
and JS2008 strains, with 5 AA insertion in two sites and 1 AA deletion in one site. In the immune protective efficiency
tests, the neutralizing antibody titers in sera, the colostrum and the milk on 7th day after farrowing of the inactivated
YC2014 PEDV strain immunized group were significantly higher than the inactivated CV777 immunized group and the
inactivated DR13 immunized group (P < 0.05). The traditional inactivated PEDV vaccines made from CV777 or DR13
could not protect piglets from YC2014 challenge, while inactivated YC2014 could provide piglets with 100 %
protection against YC2014 challenge.
Conclusions: The results showed that, great antigenicity variation had occurred to this YC2014 PEDV strain. The
YC2014 PEDV strain could provide piglets against homologous challenge. It is critical for future pathogenic and
antigenic studies, as well as for the development of effective preventive and control vaccines against PEDV.
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Background
Porcine epidemic diarrhea virus (PEDV) is an enveloped,
single-stranded, positive-sense RNA virus that is taxo-
nomically classified within the family Coronaviridae,
genus Alphacoronavirus. PEDV is the main causative
agent of porcine epidemic diarrhea (PED), a devastating
enteric disease that is characterized by watery diarrhea,
vomiting, dehydration and significant mortality in pig-
lets. Approximately 80 to 100% of PEDV-infected piglets
die within 24 h of being infected with virulent PEDV
strains, resulting in tremendous economic losses to the
swine industry [1, 2].
Since December 2010, a large-scale outbreak of diar-
rhea, characterized by watery stool, dehydration, and
vomiting, with 80 to 100 % morbidity and 50 to 90 %
mortality in suckling piglets, has been observed in swine
farms in China [3, 4]. Accumulated evidence indicates
that this large-scale outbreak of diarrhea may be caused
by highly virulent PEDV variants [5, 6]. In the present
study, a PEDV strain, YC2014, was isolated from intes-
tinal samples of suckling piglets with acute diarrhea in
2014, the evolutionary characteristics and the immune
protective efficiency of YC2014 were also determined.
Results
Identification of the isolated YC2014 PEDV strain
In the PEDV isolation and propagation experiment, the
partial gene of nucleocapsid protein was analyzed by
RT-PCR using primers N1/N2, which amplified an ap-
proximately 1 kb nucleocapsid gene fragment present in
the isolated YC2014 infected Vero cells, but not in the
blank control Vero cells (Fig. 1a). The isolated YC2014
PEDV strain was detected in the cytoplasm of infected
Vero cells by an anti-PEDV N protein polyclonal anti-
body. Red fluorescence could be observed in the YC2014
strain-infected Vero cells (Fig. 1b). The isolated YC2014
PEDV strain was confirmed to be negative for other por-
cine enteric viruses, such as rotavirus groups A, B and
C, TGEV, PRCV, calicivirus and porcine deltacoronavirus
by RT-PCR. The growth kinetics study showed that
YC2014 replicated rapidly and efficiently in Vero cells,
reaching a maximum titer >107 TCID50/ml by 48 hpi
(Fig. 2).
Sequence analysis of the isolated YC2014 PEDV strain
A total of 28,077 nucleotides were sequenced in the
isolated YC2014 PEDV strain, including the polyprotein,
S, ORF3, E, M, and N protein-encoding genes. The
sequence of YC2014 was submitted to GenBank (acces-
sion no. KU252649). The complete genomic sequence of
YC2014 and the nucleotide sequence of S gene were
aligned with sequences of published isolates using
MEGA 5.1. Phylogenetic analysis demonstrated that the
YC2014 PEDV strain was clustered with the PEDV
epidemic strains (G2 cluster, Fig. 3a and b), with >99 %
nucleotide identity to these strains. The complete gen-
ome nucleotide sequence shared 96.8 % ~ 97.8 % iden-
tities with classical CV777, DR13, JS2008, AH-M and
SD-M strains (G1 cluster). The S gene sequence of
YC2014 shared only 93.9 % ~ 94.4 % identities with the
PEDV G1 cluster, such as CV777, DR13 and JS2008
strains, with 15 nucleotide insertion in three sites (167 bp,
175 ~ 185 bp, 418 ~ 420 bp) and three nucleotide deletion
in one sites (470 ~ 472 bp). The amino acid (AA) sequence
of S gene of YC2014 shared only 92.8 % ~ 93.4 % identities
with classical CV777, DR13 and JS2008 strains, with 5 AA
insertion in two sites (AA59 ~ 62, AA140) and 1 AA
deletion in one site (AA160).
Nucleocapsid protein specific antibodies and neutralizing
antibodies detection
Nucleocapsid protein specific antibodies tests showed that
a antibody response was detected in all the inactivated
PEDV strains immunized groups 7 days after the first
immunization (Fig. 4a). The antibody levels of all the
inactivated PEDV strains immunized groups maintain
Fig. 1 Identification of the isolated YC2014 PEDV strain. a RT-PCR identification of the partial gene of nucleocapsid protein. b, c Immunofluorescence
assay (IFA) identification of the PEDV YC2014 strain in the cytoplasm of infected Vero cells
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high levels at all the testing time points, but the antibody
titers of these three groups were not significantly different
(P > 0.05). The results of PEDV neutralizing antibodies
tests showed that the neutralizing antibody levels of the
inactivated PEDV strains immunized groups gradually in-
creased until 28 days after the first immunization, and still
maintain high level at 7 days after farrowing. The neutral-
izing antibody titer in sera samples of the YC2014 PEDV
strain immunized group was significantly higher than the
other three groups (P < 0.05, Fig. 4b). The neutralizing
antibody titer in the colostrum and the milk on 7th day
after farrowing of the YC2014 PEDV strain immunized
group was also significantly higher than the other three
groups (P < 0.05, Fig. 4c).
The immune protective efficiency analysis of inactivated
YC2014
After YC2014 challenge, piglets in group one, group two
and group four showed significant acute diarrhea.
Weight gain was reduced, loss of appetite and mental
uneasiness persisted, while piglets in group three, group
five and group six showed no obvious diarrhea symp-
toms. Two days after challenge, mortality of group one,
group two and group four were 100 %. No mortality or
obvious clinical symptoms were observed in group three,
group five and group six (Table 1).
Discussion
PED can generally be controlled using a vaccine strategy.
Vaccination with killed or attenuated PEDV vaccine has
been widely carried out in China and other swine raising
countries, where PED usually manifests as a mild and
enzootic pattern (lower mortality) some years ago. How-
ever, severe acute diarrhea outbreaks associated with
high morbidity (80–100 %) and mortality (50–90 %)
were observed in suckling piglets in most areas of China
since December 2010, although most sow herds had pre-
viously been vaccinated with traditional inactivated
PEDV vaccines based on CV777 or DR13. In April 2013,
PED was diagnosed in the eastern Midwest region of the
United States, subsequently, it spread rapidly to 30
neighboring states by June 2014. Accumulative evidence
Fig. 2 The growth kinetics study of YC2014 replicated in Vero cells
Fig. 3 Phylogenetic analysis of the isolated YC2014 PEDV strain. a Phylogenetic analysis based on the complete genomic sequence of YC2014.
b Phylogenetic analysis based on the nucleotide sequence of S gene
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indicates that this large-scale outbreak of diarrhea may
be caused by highly virulent PEDV variants [7–9].
The S protein makes up the large surface projections
of the virion and plays a pivotal role in determining
viral-cellular fusion activity and activating the immune
system [10–12]. The variations in amino acid sequence
likely changed the immunogenicity of the S protein and
led to immunization failure of current commercial vac-
cines. In this study, we successfully isolated the YC2014
PEDV strain from porcine intestinal samples in dead
piglets during outbreaks of acute diarrhea. The S gene
nucleotides analysis of YC2014 indicated that it was
clustered with the PEDV epidemic strains, with 15
nucleotide insertion in three sites and three nucleotide
deletion in one site compared to classical PEDV vaccine
strains CV777 and DR13. The variations of the S gene
sequence and deduced amino acid sequence of the
YC2014 strain compared to traditional PEDV vaccine
strains may be the reason why some swine farms had
well PEDV vaccine immunizations but still had sustained
epidemic diarrhea which caused huge economic losses.
Vaccination is one of the most effective ways in
preventing PED infection. Immunization of sows with
PEDV vaccines at 20–30 days before production will
provide substantial passive immunity to the newborn
piglets [13]. In this study, the nucleocapsid protein spe-
cific antibody levels of three different inactivated PEDV
strains immunized groups gradually increased at all the
testing time points. However, the antibody titers of these
three groups are not significantly different. Immu-
nization with inactivated YC2014 could protect piglets
from acute diarrhea against homologous strain chal-
lenge. Since YC2014 was clustered with the PEDV epi-
demic strains, with >99 % nucleotide identity to most of
these epidemic strains, the inactivated YC2014 may pro-
tect other variant strains challenge in some extent. How-
ever, it needs further refine animal studies to assess this
suppose. The results showed that, great antigenicity vari-
ation had occurred to this YC2014 PEDV strain under
the selective pressure of vaccines. Therefore, it is
important to investigate PEDV variants currently cir-
culating in sow herds to assess their ability to allow for
cross-protection against highly virulent PEDV strains
and prevent PEDV epidemics.
Conclusion
The results showed that, great antigenicity variation had
occurred to this YC2014 PEDV strain. The YC2014
PEDV strain could provide piglets against homologous
challenge. It is critical for future pathogenic and
Fig. 4 Nucleocapsid protein specific antibodies and neutralizing antibodies detection. Data were shown as mean±S.D. a Nucleocapsid protein
specific antibodies detection in sera samples of the immunized sows. b Neutralizing antibodies detection in sera samples of the immunized sows.
c Neutralizing antibodies detection in the colostrum and the milk on 7th day after farrowing. * Indicates the neutralizing antibody titer of the
YC2014 PEDV strain immunized group was significantly higher than the other three groups (P < 0.05)
Table 1 Diarrhea and mortality in piglets during virus challenge
Group No. Inoculation/challenge of sows Time after challenge
12 h 24 h 36 h 48 h
Diarrheaa Mortality (%) Diarrhea Mortality (%) Diarrhea Mortality (%) Diarrhea Mortality (%)
1 5 inactivated CV777/YC2014 + 20 ++ 40 ++ 80 ++ 100
2 5 inactivated DR13/YC2014 + 0 ++ 40 ++ 60 ++ 100
3 5 inactivated YC2014/YC2014 − 0 − 0 − 0 − 0
4 5 PBS/YC2014 + 20 ++ 80 ++ 100 ++ 100
5 5 inactivated CV777/CV777 − 0 − 0 − 0 − 0
6 5 inactivated DR13/DR13 − 0 − 0 − 0 − 0
a−, no diarrhea; +, mild diarrhea; ++, severe diarrhea
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antigenic studies, as well as for the development of ef-
fective preventive and control vaccines against PEDV.
Methods
Clinical samples
In May 2014, porcine intestinal tracts, intestinal contents
and fecal samples were collected from dead piglets during
outbreaks of diarrhea on a breeding farm. This farm keeps
more than 1800 sows and located in Yancheng city within
the Jiangsu province. Clinical signs were characterized by
acute vomiting, anorexia, and watery diarrhea, with high
mortality in piglets less than 10 days old. The diarrhea
outbreaks occurred throughout the year and re-occurred
at 2–3 weeks interval.
Virus isolation and identification
Virus isolation was performed as described previously [14].
The RNA of the isolated YC2014 PEDV strain cultures
were extracted using the Viral RNA Mini kit (Geneaid
Biotech, Taiwan) according to the manufacturer’s instruc-
tions. The presence of PEDV in the Vero cell culture was
confirmed by reverse transcription PCR (RT-PCR) with
one pairs of primers to amplify approximately 1 kb partial
sequence of nucleocapsid protein, N1: GCAAACGGG
TGCCATTATCTC, N2: CTAGCTCACGAACAGCCAC
ATTAC. The samples of PEDV in the Vero cell cul-
ture were confirmed to be negative for rotavirus A, B
and C, transmissible gastroenteritis virus (TGEV),
porcine respiratory coronavirus (PRCV), caliciviruses
and porcine deltacoronavirus via RT-PCR as previ-
ously described [15–19].
The PEDV YC2014 strain was then identified with im-
munofluorescence assay (IFA). Briefly, Vero cells grown
on a 6-well plate were infected with the PEDV YC2014
strain. At 48 h post-infection, cells were washed twice
with PBS and fixed with cold methanol for 10 min
at −20 °C. Cells were then washed three times with
PBST and blocked with 10 % bovine serum albumin
(BSA) at 37 °C for 1 h. Preparations were incubated
for 1 h at 37 °C with mouse anti-PEDV nucleocapsid
protein polyclonal antibody in dilution buffer (1 %
BSA in PBST), this mouse anti-PEDV nucleocapsid
protein polyclonal antibody, prepared by our laboratory,
was collected from serum of ICR mice immunized with
purified prokaryotic expressed N protein. After three
washes with PBST, cells were treated with a rhodamine-
conjugated goat anti-mouse IgG (Cwbio, China) at a
1:5000 dilution with PBS for 30 min at 37 °C. After a final
four washes with PBST, all wells were examined using
fluorescence microscopy (Axio Observer Z1, Zeiss,
Germany). After ten passages on Vero cells, the one-step
growth curve of YC2014 strain in Vero cells was
monitored at 8 h interval after infection.
Sequence analysis of the PEDV YC2014 strain
Based on the sequence of the CV777 PEDV strain
(GenBank: AF353511.1), seven pairs of oligonucleotide
primers (Table 2) were designed to amplify the different
regions of the YC2014 genome. The PCR products were
cloned into the pUC19 vector using ClonExpress Entry One
Step Cloning Kit (Vazyme) and sequenced by Invitrogen
Biotechnology (Shanghai, China). The 5′ and 3′ ends of
the genome of YC2014 were validated using the rapid
amplification of cDNA ends (RACE) cDNA amplification
kit (Clontech, Japan). All fragments were sequenced in
both directions in triplicate. The complete genomic
sequence of YC2014 and the nucleotide sequence of S
gene were aligned with sequences of published isolates
using MEGA 5.1 software. Phylogenetic trees were con-
structed using the Maximum Likelihood method and sup-
ported with a bootstrap test of 1000 replicates. Genomic
sequences of the isolated YC2014 PEDV strain were sub-
mitted to GenBank under accession no. KU252649.
The immune protective efficiency analysis of inactivated
YC2014
All experimental protocols were approved by the
Laboratory Animal Monitoring Committee of Jiangsu
province and performed accordingly. Twelve commercial

















aLocation corresponds to position within the CV777 (AF353511.1) genome
Table 3 Inoculation of the sows
Group No. Immunogen Dose
1 3 inactivated CV777 2.0 × 107 TCID50
2 3 inactivated DR13 2.0 × 107 TCID50
3 3 inactivated YC2014 2.0 × 107 TCID50
4 3 PBS - - - -
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high-health sows (Large White) were randomly divided
into four groups (Table 3) and were housed in four
separate rooms. These sows were confirmed virologically
negative for PEDV, TGEV and porcine deltacoronavirus by
RT-PCR and serologically negative for PEDV and TGEV
antibody by indirect ELISA. On 28 and 14 days before far-
rowing, sows in group one were immunized intramuscu-
larly with 2 ml of inactivated CV777 (2.0 × 107 TCID50)
emulsified in equal volume of Gel 01 ST adjuvant (Seppic,
France), separately. Group two were immunized intramus-
cularly with 2 ml of inactivated DR13 (2.0 × 107 TCID50)
emulsified in equal volume of Gel 01 ST adjuvant. Group
three were immunized intramuscularly with 2 ml of inacti-
vated YC2014 (2.0 × 107 TCID50) emulsified in equal vol-
ume of Gel 01 ST adjuvant. Group four were treated with
2 ml of saline emulsified in equal volume of Gel 01 ST
adjuvant. After immunization, sera samples were collected
from sows at 7-day intervals until 35 days after im-
munization (7 days after farrowing) for detection of
nucleocapsid protein specific antibodies with commercial
indirect ELISA kits (Biovet, Canada) and PEDV neutraliz-
ing antibodies using YC2014 as indicator virus as de-
scribed previously [20]. Briefly, 50 μl of PEDV strain
YC2014 (2.0 × 103 TCID50/ml) was added to an equal vol-
ume of the sera samples and incubated for 1 h at 37 °C.
The mixture was then inoculated to a 96-well plate con-
taining confluent Vero cells. 2 h later, the culture plate
was washed with D-Hank’s three times, and then added
100 μl of DMEM containing 2 % fetal bovine serum (FBS).
48 h later, the culture plate was fixed with cold methanol
for 10 min at −20 °C, and incubated with mouse anti-
PEDV nucleocapsid protein polyclonal antibody for 1 h at
37 °C, and then stained with FITC-labeled rabbit anti-
mouse IgG (Santa Cruz Biotechnology). The serum titers
were determined as the reciprocal of the last serum dilu-
tion at 70 % or greater fluorescent focus reduction in the
infected cell cultures under a fluorescent microscope. The
colostrum and the milk on 7th day after farrowing of each
sow were also collected and used for the detection of
PEDV neutralizing antibodies.
The average number of sows farrowing was 13, piglets
in each group was coded and chosen randomly, respect-
ively. On 7th day after farrowing, thirty piglets were
chosen (Table 4), ten from group one (inactivated
CV777 immunized group), ten from group two (inacti-
vated DR13 immunized group), five from group three
(inactivated YC2014 immunized group), and five from
group four (saline treated group). These piglets were di-
vided into six groups (Table 4), each group were housed
in a separate room and were artificial feeding with milk.
Piglets in group one to group four were challenged or-
ally with 1.0 × 104 TCID50 of YC2014. Group five were
challenged orally with 1.0 × 104 TCID50 of CV777.
Group six were challenged orally with 1.0 × 104 TCID50
of DR13. Piglets were observed daily after challenge
about the diarrhea symptoms.
Statistical analysis
All data were analyzed using one-way ANOVA and values
of P < 0.05 were considered statistically significant.
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